J Neurosurg Sci:碧萝芷可增强婴儿潮这代人的的认知功能

2015-12-23 MedSci MedSci原创

碧萝芷是法国沿海松树皮的提取物,可提高身体健康但是氧化应激水平较高人群的认知功能。该研究结果在线发表于Journal of Neurosurgical Sciences。

碧萝芷是法国沿海松树皮的提取物,可提高身体健康但是氧化应激水平较高人群的认知功能。该研究结果在线发表于Journal of Neurosurgical Sciences。

来自佩斯卡拉的研究人员进行了为期12个月的研究,研究对象聚焦于称之为“婴儿潮”这一代的人群,这代人现在的年龄在55-70岁之间。

最终研究共纳入了77名研究对象。研究人员比较了在进行一系列生活方式项目的同时每天使用100mg碧萝芷的研究对象的认知参数与那些仅进行一系列生活方式测量研究对象的认知参数。

此外,研究人员还对比了试验组和对照组研究对象的氧化应激水平差异。

结果发现,补充碧萝芷可提高机体的认知,同时还可降低机体氧化应激的水平。

去年的一个研究报道了相似的结果:碧萝芷可降低年龄在33-55岁之间的健康人群的氧化应激水平。

降低了28%的氧化应激水平

该研究中,试验组研究对象做决定的能力较未使用碧萝芷前明显提高71%,而在对照组研究对象做决定的能力则下降了5%。

实验组研究对象的记忆力可显著提高37.3%,而对照组研究对象则降低了9.8%。

在注意广度方面,补充碧萝芷的研究对象则有41.2%的提高,而对照组仅提高了1.9%。

此外,研究人员还发现,试验组研究对象在补充碧萝芷后,其氧化应激的水平显著降低了28%,而对照组却没有任何变化。

在生活方式项目上研究对象需按照以下要求来实施:每晚至少睡8小时,不能迟于10:30入睡,在确定的时间点规律饮食,并减少咖啡因、盐、糖以及酒精的摄入,每天至少锻炼20分钟。

最后,Dr. Belcaro说道,碧萝芷或可通过联合抗炎、抗氧化以及抗水肿活性来作用于机体的认知功能和注意力。

原始出处:

Jill Stein. Pycnogenol bolsters cognitive function in baby boomers. MNT, 18 December 2015.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1364079, encodeId=b52e13640e948, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Fri Dec 25 07:45:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47522, encodeId=be8b4e522ac, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Thu Dec 24 19:18:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47476, encodeId=78144e476f6, content=与VitC有差别不, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec561664738, createdName=flyfar, createdTime=Thu Dec 24 16:34:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47473, encodeId=eb524e473dd, content=中药吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 24 15:35:00 CST 2015, time=2015-12-24, status=1, ipAttribution=)]
    2015-12-25 lsndxfj
  2. [GetPortalCommentsPageByObjectIdResponse(id=1364079, encodeId=b52e13640e948, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Fri Dec 25 07:45:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47522, encodeId=be8b4e522ac, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Thu Dec 24 19:18:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47476, encodeId=78144e476f6, content=与VitC有差别不, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec561664738, createdName=flyfar, createdTime=Thu Dec 24 16:34:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47473, encodeId=eb524e473dd, content=中药吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 24 15:35:00 CST 2015, time=2015-12-24, status=1, ipAttribution=)]
    2015-12-24 zhuzhuba1

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1364079, encodeId=b52e13640e948, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Fri Dec 25 07:45:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47522, encodeId=be8b4e522ac, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Thu Dec 24 19:18:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47476, encodeId=78144e476f6, content=与VitC有差别不, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec561664738, createdName=flyfar, createdTime=Thu Dec 24 16:34:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47473, encodeId=eb524e473dd, content=中药吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 24 15:35:00 CST 2015, time=2015-12-24, status=1, ipAttribution=)]
    2015-12-24 flyfar

    与VitC有差别不

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1364079, encodeId=b52e13640e948, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Fri Dec 25 07:45:00 CST 2015, time=2015-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47522, encodeId=be8b4e522ac, content=牛, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c10c75714, createdName=zhuzhuba1, createdTime=Thu Dec 24 19:18:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47476, encodeId=78144e476f6, content=与VitC有差别不, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec561664738, createdName=flyfar, createdTime=Thu Dec 24 16:34:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47473, encodeId=eb524e473dd, content=中药吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Dec 24 15:35:00 CST 2015, time=2015-12-24, status=1, ipAttribution=)]
    2015-12-24 xiaotaiyang1

    中药吗

    0